Galen 3100 exam 3
polyuria - ANS-excessive production of urine; 2500mL or more per day
oliguria - ANS-reduced urine output; less than 500ml per day
nocturia - ANS-excessive urination at night
dysuria - ANS-painful urination
hematuria - ANS-presence of blood in the urine
urinary incontinence - ANS-inability to control urination
urinary retention - ANS-inability to empty the bladder
stress incontinence - ANS-the inability to control the voiding of urine under physical stress such
as running, sneezing, laughing, or coughing
urge incontinence - ANS-the loss of urine in response to a sudden, urgent need to void; the
person cannot get to a toilet in time
mixed incontinence - ANS-the combination of stress incontinence and urge incontinence
functional incontinence - ANS-state in which a person experiences an involuntary,
unpredictable passage of urine
overflow incontinence - ANS-continuous leaking from the bladder either because it is full or
because it does not empty completely
Temporary inconvenience - ANS-Occur in association with factors as sever constipation,
infections, and or medication usage
enuresis - ANS-involuntary discharge of urine
Hemoglobin ( Hgb) - ANS-• Females 12-16 g/dL
• Males 14-18 g/dL
Hematocrit ( Hct) - ANS-• Females 37-47%
• Males 42-52%
, White Blood Cell ( WBC) - ANS-5-10 mm3 ( both sexes)
Glucose ( Glu) - ANS-70-110 mg/dL ( both sexes)
Sodium ( NA) - ANS-135-145 mEq/L ( both sexes)
Potassium ( K) - ANS-3.5-5.0 mEq/L ( both sexes)
Creatinine ( n/a) - ANS-males 0.6 - 1.2 mg/dL; female 0.5-1.1 mg/dL
Blood Urea Nitrogen ( BUN) - ANS-10-20 mg/dL ( both sexes)
Red Blood Cell ( RBC) - ANS-Male: 4.7-6.1 mm3
Female: 4.2-5.4 mm3
specific gravity - ANS-1.010-1.030
SQ injections are given where? - ANS-Adipose tissues
SQ injections syringe - ANS-1/2-3 mL or U-100 insulin syringe
SQ injections needle - ANS-25-31 gauge
3/8 to 5/8 inches ( up to 1 inch in obese PT)
IM injections are given where - ANS-muscle tissue
IM injections syringe - ANS-2-5mL ( adults)
0.5 to 1 mL ( pediatric)
IM Injections needle - ANS-19-25 gauge
1-3 inches ( adult)
22-25 gauge, 5/8 to inch ( pediatric)
Intradermal injection sites - ANS-inner surface of the forearm and the upper back under the
scapula.
Intradermal Injections syringe - ANS-Up to 0.1ml tuberculin syringe
Intradermal Injections needle - ANS-25 to 27 gauge, 1/4 to 5/8 inch
types of laxative - ANS-bulking forming , agents, osmotic, saline, stimulants, and stool softeners
esophagoscopy - ANS-visual examination of the esophagus
polyuria - ANS-excessive production of urine; 2500mL or more per day
oliguria - ANS-reduced urine output; less than 500ml per day
nocturia - ANS-excessive urination at night
dysuria - ANS-painful urination
hematuria - ANS-presence of blood in the urine
urinary incontinence - ANS-inability to control urination
urinary retention - ANS-inability to empty the bladder
stress incontinence - ANS-the inability to control the voiding of urine under physical stress such
as running, sneezing, laughing, or coughing
urge incontinence - ANS-the loss of urine in response to a sudden, urgent need to void; the
person cannot get to a toilet in time
mixed incontinence - ANS-the combination of stress incontinence and urge incontinence
functional incontinence - ANS-state in which a person experiences an involuntary,
unpredictable passage of urine
overflow incontinence - ANS-continuous leaking from the bladder either because it is full or
because it does not empty completely
Temporary inconvenience - ANS-Occur in association with factors as sever constipation,
infections, and or medication usage
enuresis - ANS-involuntary discharge of urine
Hemoglobin ( Hgb) - ANS-• Females 12-16 g/dL
• Males 14-18 g/dL
Hematocrit ( Hct) - ANS-• Females 37-47%
• Males 42-52%
, White Blood Cell ( WBC) - ANS-5-10 mm3 ( both sexes)
Glucose ( Glu) - ANS-70-110 mg/dL ( both sexes)
Sodium ( NA) - ANS-135-145 mEq/L ( both sexes)
Potassium ( K) - ANS-3.5-5.0 mEq/L ( both sexes)
Creatinine ( n/a) - ANS-males 0.6 - 1.2 mg/dL; female 0.5-1.1 mg/dL
Blood Urea Nitrogen ( BUN) - ANS-10-20 mg/dL ( both sexes)
Red Blood Cell ( RBC) - ANS-Male: 4.7-6.1 mm3
Female: 4.2-5.4 mm3
specific gravity - ANS-1.010-1.030
SQ injections are given where? - ANS-Adipose tissues
SQ injections syringe - ANS-1/2-3 mL or U-100 insulin syringe
SQ injections needle - ANS-25-31 gauge
3/8 to 5/8 inches ( up to 1 inch in obese PT)
IM injections are given where - ANS-muscle tissue
IM injections syringe - ANS-2-5mL ( adults)
0.5 to 1 mL ( pediatric)
IM Injections needle - ANS-19-25 gauge
1-3 inches ( adult)
22-25 gauge, 5/8 to inch ( pediatric)
Intradermal injection sites - ANS-inner surface of the forearm and the upper back under the
scapula.
Intradermal Injections syringe - ANS-Up to 0.1ml tuberculin syringe
Intradermal Injections needle - ANS-25 to 27 gauge, 1/4 to 5/8 inch
types of laxative - ANS-bulking forming , agents, osmotic, saline, stimulants, and stool softeners
esophagoscopy - ANS-visual examination of the esophagus
